Concepedia

Jane L. Liesveld

JL

160

Publications

11.9K

Citations

57

H-Index

1988

Active since

Affiliations

University of Rochester Medical Center(Current)

University of Rochester

Medical College of Wisconsin

Fred Hutch Cancer Center

Dana-Farber Cancer Institute

Jane L. Liesveld is an author at University of Rochester Medical Center specializing in medicine, hematology, and immunology.

ORCID

Top concepts

Publications per year

1988–2025

160

Publications

160

BCL-2 Inhibition Targets Oxidative Phosphorylation and Selectively Eradicates Quiescent Human Leukemia Stem Cells

Eleni D. Lagadinou, Alexander Sach, Kevin P. Callahan et al. · Cell stem cell · 2013 · 1.3K citations · Full text

, , +8

Long-Lived Plasma Cells Are Contained within the CD19−CD38hiCD138+ Subset in Human Bone Marrow

Jessica L. Halliley, Christopher M. Tipton, Jane L. Liesveld et al. · Immunity · 2015 · 510 citations · Full text

, , +8

Clinical and biologic activity of the farnesyltransferase inhibitor R115777 in adults with refractory and relapsed acute leukemias: a phase 1 clinical-laboratory correlative trial

Judith E. Karp, Jeffrey E. Lancet, Scott H. Kaufmann et al. · Blood · 2001 · 445 citations · Full text

Rapid Mobilization of CD34+ Cells Following Administration of the CXCR4 Antagonist AMD3100 to Patients With Multiple Myeloma and Non-Hodgkin's Lymphoma

Steven M. Devine, Neal Flomenberg, David H. Vesole et al. · Journal of Clinical Oncology · 2004 · 415 citations · Full text

An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells

Mónica L. Guzmán, Randall M. Rossi, Sundar Neelakantan et al. · Blood · 2007 · 407 citations · Full text

Rows per page

1–5 of 160